Institutional
9 de August de 2017
Published ANVISA’s new rule relative to the prior consent for the granting of a patent for pharmaceutical products and processes
Valid since August 10 2017 – date of its publication on the Official Federal Gazette – this new rule confirms all the principals and procedures already stated on Normative Instruction Nº 01, from May 31 2017.
In case you need further information on this topic, our legal and technical teams are at your disposal in our offices of Rio de Janeiro, São Paulo and Porto Alegre, as well as the email: mail@kasznarleonardos.com
Back
Share:
Last related news
10 de February de 2026
Kasznar Leonardos was ranked in 2025 Outstanding International IP Service Teams
We are honored to announce that, for the second year in a row, we have been recognized in the “Outstanding International IP … Kasznar Leonardos was ranked in 2025 Outstanding International IP Service Teams
28 de January de 2026
Kasznar Leonardos is ranked on WTR 1000 2026
We are honored to announce that Kasznar Leonardos has been ranked as a reference firm in the Trademarks area, Gold category, by … Kasznar Leonardos is ranked on WTR 1000 2026
13 de November de 2025
Kasznar Leonardos is ranked by Best Lawyers 2026
We are honored to announce that Kasznar Leonardos has been recognized as Intellectual Property Firm of the Year by Best Lawyers Brazil … Kasznar Leonardos is ranked by Best Lawyers 2026